A monoclonal antibody cocktail against the COVID-19 virus discovered at Vanderbilt University Medical Center and developed by AstraZeneca reduced the risk of symptoms in a study of immunocompromised and chronically ill adults ...
Aug 20, 2021
0
150
A survey of more than 17,000 pregnant and lactating individuals who received the COVID-19 vaccine showed that the individuals did not experience symptoms any more severe than their non-pregnant counterparts.
Aug 17, 2021
0
11
COVID-19 breakthrough infections—where a fully vaccinated person becomes infected with the coronavirus—are occurring across the globe, due, in large part, to the highly contagious Delta variant. Here in the United States, ...
Aug 13, 2021
0
7
A South Australian-developed SARS-CoV-19 vaccine is preparing to progress to final stages of human clinical trials after early animal testing confirmed its safety and effectiveness in preventing COVID-19 lung infection.
Aug 12, 2021
0
5
China's drug regulator has approved the country's first mixed-vaccine trial, a company involved in the study said, as the rapid spread of the Delta variant raises concern about the efficacy of domestically produced jabs.
Aug 11, 2021
0
106
Spain's medicines agency approved Tuesday a first round of clinical trials on humans for a COVID-19 vaccine developed by Spanish firm Hipra.
Aug 11, 2021
0
41
Moderna said Thursday that protection from its COVID-19 vaccine remained strong for at least six months, and the variant-specific boosters shot it is testing generated a "robust" antibody response to Delta.
Aug 5, 2021
0
4
Lyme disease has become an insidious epidemic in the United States. Caused by bacteria transmitted through the bite of an infected tick, it can lead to heart problems, meningitis or arthritis if left untreated. It is the ...
Aug 4, 2021
0
198
Over a year into the pandemic, questions around immune responses after COVID continue to confound.
Aug 2, 2021
0
133
Imagine a COVID-19 vaccine that came as a pill: no needles, no medical professionals required to administer it, potentially delivered directly to people's homes.
Aug 1, 2021
0
121
